Some studies have suggested that reduced DNA‐PK activity could lead to cancer because DNA‐PK is used to repair defects, while higher DNA‐PK expression and activity has been observed in other tumor cells and is correlated with reduced efficiency of anti‐tumor drugs.39 This evidence concerns the gene PRKDC and cancer.